Evaluating When and Why Patients Discontinue Chronic Therapy for Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation

INTRODUCTION: To inform the patient-centered discussion regarding comparative outcomes with irritable bowel syndrome/chronic idiopathic constipation pharmacotherapy, we evaluated reasons and timing of discontinuation of FDA-approved pharmacotherapy for irritable bowel syndrome and chronic idiopathic...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Gastroenterol
Main Authors: Shah, Eric D., Suresh, Suraj, Jou, Jessica, Chey, William D., Stidham, Ryan W.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565170/
https://ncbi.nlm.nih.gov/pubmed/32022721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000530
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares